Victory Capital Management Inc Seres Therapeutics, Inc. Transaction History
Victory Capital Management Inc
- $95.7 Billion
- Q4 2024
A detailed history of Victory Capital Management Inc transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 15,439 shares of MCRB stock, worth $11,733. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,439
Previous 15,306
0.87%
Holding current value
$11,733
Previous $14,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding MCRB
# of Institutions
75Shares Held
41.3MCall Options Held
2.96MPut Options Held
228K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$17.6 Million5.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$4.46 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.01MShares$1.53 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.81MShares$1.38 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$1.34 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $94.3M
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...